Pearls and Pitfalls {#FPar1}
===================

Acute liver failure is a common pathway for many conditions and insults, leading to massive hepatic necrosis and/or loss of normal hepatic function.Transaminases can be elevated secondary to many intra- and extrahepatic causes.The level of transaminitis should not be the sole determinant in management and disposition.Patients with acute liver failure should be considered for early transfer to a liver transplant center, ideally prior to elevation in intracranial pressure or the development of severe coagulopathy.

When Does Transaminitis Become Acute Hepatic Failure? {#Sec1}
=====================================================

Transaminases (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)) are frequently obtained in the acute care setting \[[@CR1]--[@CR3]\]. Non-toxicological causes of elevated transaminases include infection, ischemia, metabolic derangement, malignancy, autoimmune disease, and primary graft failure after transplant \[[@CR1]\].

Acute Hepatic Failure {#Sec2}
---------------------

Non-toxicological causes of acute liver failure are listed in Table [69.1](#Tab1){ref-type="table"} \[[@CR1]\]. Toxicological causes of acute liver failure are listed in Table [69.2](#Tab2){ref-type="table"} \[[@CR1]\]. Viral hepatitis is the most common cause of acute liver failure worldwide, while acetaminophen is the most common cause of acute liver failure in the United States \[[@CR3]\]. Acute liver failure is a common pathway for many conditions and insults, leading to massive hepatic necrosis and/or loss of normal hepatic function.Table 69.1Non-toxicological causes of acute liver failure^a^InfectionIschemiaMetabolic derangementsMalignancyAutoimmune problemsPrimary graft failure after transplantViral hepatitis (hepatitis A&E most common)Disruption of portal vein or hepatic arteryAcute fatty liver of pregnancyAny malignancy causing obstruction or liver damageAutoimmune hepatitisLiver transplant failureHerpes simplex, EBV, varicella zoster, CMV, parvovirus (usually immunocompromised if acute liver failure occurs from these)Prolonged hypotension (overdose, cardiac arrest, intraoperative, AMI, PE)HELLP syndromeRare: *Coxiella burnetii*, *Plasmodium falciparum*, amebic abscesses, disseminated TB, *Bacillus cereus*Veno-occlusive disease (chemotherapy or bone marrow transplant related)Reye's syndromeBudd-Chiari syndromeWilson's diseaseExertional heat stroke*EBV* Epstein-Barr virus, *CMV* cytomegalovirus, *TB* tuberculosis, *AMI* acute myocardial infarction, *PE* pulmonary embolism, *HELLP* hemolysis, elevated liver enzymes, low platelets^a^Not an all-inclusive listTable 69.2Toxicological causes of acute liver failure^a^PharmaceuticalsDrugs of abuseChemicalsBiologic agentsAcetaminophenCocaineCCl~4~Sea anemone stingRare/idiosyncratic/unpredictable (valproic acid, troglitazone, amiodarone)MDMAChloroformMushrooms (cyclopeptides)Hypersensitivity reactions (phenytoin, para-aminosalicylate, chlorpromazine, sulfonamides)PCPHalothaneHalogenated anesthetics (enflurane, methoxyflurane, isoflurane, halothane): toxic hepatitis, rare FHFTCE (inhaled)Cleaning solvents with fluorinated or halogenated hydrocarbonsNSAIDs: sulindac, diclofenacToluene (inhaled)Macrolides (erythromycin, clarithromycin): cholestasis, rare hepatic necrosisEthanolOther medications: aspirin, amoxicillin-clavulanate, azathioprine, infliximab, carbamazepine, captopril, tetracycline, zidovudine, dantrolene, herbal meds (kava), dapsone, diltiazem, statins, methimazole, MAOIs, methotrexate, nitrofurantoin, TCAs, phenothiazines, gold, propylthiouracil, isoniazid, rifampin, ketoconazole, methyldopa*FHF* fulminant hepatic failure, *NSAIDs* nonsteroidal anti-inflammatory drugs, *MAOIs* monoamine oxidase inhibitors, *TCAs* tricyclic antidepressants, *MDMA* 3,4-methylenedioxymethamphetamine, *PCP* phencyclidine, *TCE* trichloroethylene^a^Not an all-inclusive list

Acute liver failure can be classified into subgroups by acuity of encephalopathy. Hyperacute liver failure is encephalopathy within 1 week of jaundice onset. Acute liver failure is encephalopathy within 8--28 days of jaundice onset. Subacute liver failure is encephalopathy within 5--12 weeks of jaundice onset \[[@CR4], [@CR5]\].

Complications {#Sec3}
-------------

Each subgroup has its own set of complications. Hyperacute and acute liver failure have an increased incidence of cerebral edema, but hyperacute liver failure patients are more likely to survive with supportive care, and acute liver failure patients are more likely to die without liver transplant. Subacute liver failure patients have increased mortality, less cerebral edema, and increased likelihood of portal hypertension, leading to ascites and renal failure \[[@CR5]\].

Other complications from acute liver failure include \[[@CR5]\]:Bleeding (including exsanguination)Cardiovascular derangementsPulmonary and ventilatory derangementsCentral nervous system dysfunction (temperature dysregulation causing hypothermia, disruption of the blood-brain barrier, and increased intracranial pressure leading to encephalopathy)Metabolic derangementsInfection

The higher the number of complications, the more likely the patient will not survive \[[@CR1]\].

Overall, outcomes have improved due to earlier identification of causes, earlier initiation of treatment, improved intensive care, and improved transplant science. Formerly, mortality was 55--95%, and now mortality is 30--40% \[[@CR4], [@CR6]\].

Laboratory Abnormalities {#Sec4}
------------------------

Liver failure generally results in laboratory abnormalities beyond transaminitis. Blood work in acute liver failure may show \[[@CR1], [@CR7]\]:Synthetic dysfunction, which is usually the first sign of impending liver failure -- decreased albumin and clotting factor levels, increased coagulation profilesDefects in gluconeogenesis -- decreased serum glucoseWorsening toxicant metabolism -- increased ammoniaDecreased hepatic excretory function -- increased bilirubinDecreased renal function -- elevated creatinine from prerenal azotemia, acute tubular necrosis, and/or hepatorenal syndrome

Table [69.3](#Tab3){ref-type="table"} reviews the utility of labs , imaging, and other ancillary tests in the evaluation of potential acute hepatic failure \[[@CR1], [@CR3], [@CR8]\].Table 69.3Initial diagnostic testing in fulminant hepatic failureParameterRationaleElectrolytes and mineralsImbalances are common. Abnormalities can cause arrhythmias and worsen encephalopathy. Hypophosphatemia is common in acetaminophen overdoseBUN/creatinineRenal failure is frequent and affects management and prognosis. Etiology (e.g., toxic effect of ingested substances) may alter therapy (e.g., hemodialysis)GlucoseHypoglycemia is common and can produce permanent neurologic sequelaeCBC with plateletsAssess for sepsis (leukocytosis), GI bleeding (anemia), and risk of hemorrhage (thrombocytopenia)Liver profileAssess for degree of damage and follow course of illness. Elevated transaminases are generally due to hepatocyte damage. Increase in alkaline phosphatase is usually due to cholestasis or biliary obstruction. Increased bilirubin with indirect/direct can guide differentialAmmoniaIncreased in hepatic metabolic failure. Poor prognosis if significantly increased in fulminant hepatic failureCoagulation profileServe as prognostic indicators (protime, factor V level) and assess risk of hemorrhageArterial blood gasesPrognostic significance (lactic acidosis). Derangements are commonBlood groupPreparation for transplantation. Type and crossmatch in anticipation of bleedingToxicology, virology, autoimmune panel, ceruloplasmin, medication historyEtiology affects management (e.g., NAC for acetaminophen, charcoal for *Amanita*) and prognosisBlood and urine culturesSurveillance for sepsis; aggressive treatment warranted if positiveECGMay affect management. Preparation for transplantationChest radiographSepsis surveillance. Evaluate for ARDS and pulmonary edemaAbdominal ultrasoundEvaluate for vascular thrombosis and infection. Preparation for transplantationIntracranial pressureAssess ICP if stage III--IV encephalopathy present. Cerebral edema is the most common cause of death*ARDS* adult respiratory distress syndrome, *BUN* blood urea nitrogen, *CBC* complete blood count, *ECG* electrocardiogram, *ALF* acute liver failure, *GI* gastrointestinal, *ICP* intracranial pressure, *NAC* N-acetylcysteine, *PT* prothrombin time

Non-hepatic Transaminitis {#Sec5}
-------------------------

In the appropriate clinical setting , elevations in AST and ALT should prompt the clinician to consider rhabdomyolysis and order a creatinine kinase level. Rhabdomyolysis-induced transaminitis occurs secondary to AST (and some ALT) release from muscle breakdown. In the past, ALT was considered liver-specific, but ALT elevations may occur in patients with myopathy but no liver disease \[[@CR9]\]. Hypoperfusion from other medical issues can lead to transaminitis as well.

Prognostication {#Sec6}
---------------

The King's College Criteria is used to determine potential for liver transplant in both acetaminophen toxicity and other causes of acute liver failure.

The King's College Criteria for acetaminophen toxicity suggests transplant if \[[@CR4], [@CR10]\]:pH \<7.3 (irrespective of other factors)Grade III--IV encephalopathy (Table [69.4](#Tab4){ref-type="table"}) *and* protime \>100 s *and* serum creatinine \>3.4 mg/dLTable 69.4Stages of clinical hepatic encephalopathyStageLevel of consciousnessNeuromuscular changesBehavioral/intellectual changesIReversal of sleep patternMild confusionMild asterixisImpaired handwritingEuphoria/depressionShort-term memory lapsesIISlow responsesIncreasing drowsinessAsterixis/ataxiaSlurred speechInappropriate behaviorLoss of time/amnesiaIIIDisorientationSomnolenceRigidity/spasticityLoss of continenceStuporous/incoherentMarked confusion/paranoiaIV A/BComatoseA: Responds to painB: No response to painDecorticate/decerebrate posturingHyperreflexicComatose

The King's College Criteria for non-acetaminophen toxicity suggests transplant if \[[@CR4], [@CR10]\]:PT \>35 sINR \>7.7Any three of the following:Age \<10 or \>40 years oldUnfavorable etiology (non-A and non-B hepatitis, idiosyncratic drug reaction, halothane hepatitis, Wilson's disease)Serum bilirubin \>17 mg/dLTime from jaundice to encephalopathy \>7 daysINR \>4

The Acute Physiology and Chronic Health Evaluation III Score (APACHE III Score) may also identify those in need of liver transplant \[[@CR11]\].

What Is the Management of Transaminitis and Acute Hepatic Failure? {#Sec7}
==================================================================

Transaminitis {#Sec8}
-------------

Initial management of acute transaminitis includes fluid resuscitation, pain management, and nausea management. Generally, the cause of transaminitis will determine treatment and disposition. Transaminase values alone do not determine disposition. Admission is recommended for higher-risk (elderly and pregnant) patients or when there is no response or poor response to supportive care. It is also recommended for bilirubin ≥20 mg/dL, PT \>50% above normal, hypoglycemia, spontaneous bacterial peritonitis, new or worsening hepatic encephalopathy, hepatorenal syndrome, or coagulopathy with bleeding. Additionally, the patient should be admitted if the he or she cannot ambulate safely or if there is an unsafe home condition. Any patient with acetaminophen toxicity (using the Rumack-Matthew nomogram) should be admitted, even if the transaminases and coagulation factors are normal \[[@CR8]\].

Acute Hepatic Failure {#Sec9}
---------------------

Patients with acute liver failure should be considered for early transfer to a liver transplant center, ideally prior to intracranial pressure elevation or development of severe coagulopathy \[[@CR1]\]. Prophylactic treatment of coagulopathy is unnecessary. Fresh frozen plasma or factor VII should be given if there is active bleeding or before invasive procedures \[[@CR12]\]. Patients with grade IV encephalopathy generally require intubation. Providers should elevate the head of bed to 10--20 ° and consider avoiding positive end-expiratory pressure if possible (grade III recommendation) \[[@CR13]\]. With cerebral edema, intracranial pressure monitoring and decompression may be necessary.

Antidotes and Specific Treatments {#Sec10}
---------------------------------

Specific antidotes exist for acetaminophen toxicity (n-acetylcysteine) and for *Amanita* mushroom poisoning (silibinin and intravenous penicillin G). Shock liver will improve with the restoration of perfusion. Herpes causing transaminitis can be treated with acyclovir. Acute Budd-Chiari syndrome (thrombosis of the hepatic veins) can be treated with transjugular intrahepatic portosystemic shunt (TIPS), surgical decompression, or thrombolysis. Autoimmune hepatitis can be treated with steroids. Idiosyncratic drug-induced transaminitis can be treated with withdrawal of the drug. Rechallenge of the drug should not be performed unless there is no alternate therapy \[[@CR1]\].
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